#aptorum

Collection of aptorum news, found 11 news.

Aptorum Group announces submission of Clinical Trial Application

Aptorum Group announces submission of Clinical Trial Application

  • 22nd December 2020

Regulatory News:     Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum ...

Aptorum Group collaborates with Covar Pharmaceuticals to investigate at least 3 repurposed drug candidates (SACT-COV19) for coronavirus disease 2019 (COVID-19)

Aptorum Group collaborates with Covar Pharmaceuticals to investigate at least 3 repurposed drug candidates (SACT-COV19) for coronavirus disease 2019 (COVID-19)

  • 31st March 2020

- Aptorum Group Limited (Nasdaq: APM) ("Aptorum Group"), a biopharmaceutical company focused on the development of ...

Aptorum Group commences commercialization of dioscorea opposita bioactive nutraceutical tablets and signed sales distribution agreement in Hong Kong

Aptorum Group commences commercialization of dioscorea opposita bioactive nutraceutical tablets and signed sales distribution agreement in Hong Kong

  • 25th February 2020

- Aptorum Group Limited (“Aptorum Group”), a pharmaceutical company focused on the development of novel ...

Aptorum Group announces significant progress of repurposed drug candidate, SACT-1 for neuroblastoma targeting IND submission in H2 2020

Aptorum Group announces significant progress of repurposed drug candidate, SACT-1 for neuroblastoma targeting IND submission in H2 2020

  • 11th February 2020

- Aptorum Group Limited (Nasdaq: APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of ...

Aptorum Group announces further positive data for its ALS-4 small molecule Anti-virulence (Non-bactericidal) drug candidate for the treatment of infections caused by Staphylococcus aureus and on track

Aptorum Group announces further positive data for its ALS-4 small molecule Anti-virulence (Non-bactericidal) drug candidate for the treatment of infections caused by Staphylococcus aureus and on track

  • 10th February 2020

- Aptorum Group Limited (NASDAQ: APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of ...

Aptorum Group has initiated IND-enabling studies for its ALS-4 small molecule candidate for the treatment of infections caused by staphylococcus aureus including MRSA

Aptorum Group has initiated IND-enabling studies for its ALS-4 small molecule candidate for the treatment of infections caused by staphylococcus aureus including MRSA

  • 9th September 2019

- Aptorum Group Limited (Nasdaq: APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of ...

Aptorum Group announces the development of microbiome drug candidate targeting obesity and repurposed drug candidates targeting neuroblastoma

Aptorum Group announces the development of microbiome drug candidate targeting obesity and repurposed drug candidates targeting neuroblastoma

  • 9th September 2019

- Aptorum Group Limited (Nasdaq: APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of ...

Aptorum Group’s subsidiary Smart Pharma announces Smart Pharma token (SMPT) to be listed on IDAX and LATOKEN

Aptorum Group’s subsidiary Smart Pharma announces Smart Pharma token (SMPT) to be listed on IDAX and LATOKEN

  • 8th July 2019

- Aptorum Group Limited (Nasdaq: APM) subsidiary Smart Pharmaceutical is excited to announce that the Smart Pharma ...

Aeneas Capital and Pyrinas target launch of US$120m fund to develop co-working laboratory ecosystems for life sciences start-ups in the United States

Aeneas Capital and Pyrinas target launch of US$120m fund to develop co-working laboratory ecosystems for life sciences start-ups in the United States

  • 16th May 2019

    • Aeneas Capital and Pyrinas, both affiliated companies to Aptorum Group Ltd (Nasdaq: APM), is ...

Aptorum Group establishes Smart Pharma to Focus on Computational Repurposed Drug Discovery for Orphan and unmet Diseases

Aptorum Group establishes Smart Pharma to Focus on Computational Repurposed Drug Discovery for Orphan and unmet Diseases

  • 24th April 2019

- Aptorum Group Limited (Nasdaq: APM) today announced the establishment of a new subsidiary group, Smart Pharma ...

CORPHUB Hong Kong’s Most Outstanding Services Award 2019

CORPHUB Hong Kong’s Most Outstanding Services Award 2019

  • 8th April 2019

- Presented by CORPHUB, Hong Kong’s Most Outstanding Service Awards Ceremony 2019 was successfully held on 21st ...